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Abstract
Adequate fetal and neonatal development depend upon the pres-
ence of a normal acid-base environment during pregnancy and the
smooth transition from intra-uterine to extra-uterine life. Current
methods to assess fetal pH and acid-base status are invasive and carry
significant maternal and fetal risks. Given these limitations, obstet-
rical care providers developed the electronic fetal monitoring (EFM)
system, a non-invasive tool, which evaluates beat-to-beat fetal heart
rate (FHR) patterns in order to predict fetal oxygenation status in real-
time. Every year, about 85 percent of the approximately 4 million live
births in the United States are evaluated using EFM. Unfortunately,
though there is ample physiological evidence that FHR patterns are
inextricably linked to fetal acid-base status, the use of EFM has not
been shown to reliably predict neonatal pH, nor has it reduced the in-
cidence of adverse perinatal outcomes, including long-term neurologi-
cal morbidity and cerebral palsy (CP). The poor specificity associated
with the current interpretation of the EFM therefore leads to a para-
dox we have henceforth defined as the “Obstetrical Paradox”. In this
study, we develop and seek to determine whether a novel, non-invasive
method known as the FETAL technique (Fourier Evaluation of Trac-
ings and Acidosis in Labor), which applies the Fourier Transform to
EFM tracings and determines the spectral frequency distributions of
the FHR, improves the assessment of the fetal pH in real time. We
hypothesize that the improvement in the sensitivity and specificity of
the EFM with the use of the FETAL technique will lead to a signifi-
cant reduction in the rate of neonatal hypoxic injury and in the rate
of caesarean and assisted vaginal deliveries for suspected fetal distress.
The implications of a successful application of the FETAL technique
would have paradigm-shifting consequences in the provision of modern
obstetrical care.
∗To whom correspondence should be addressed: Dr. Jacques Balayla MD, MPH,
FRCSC. Quilligan Scholar. e-mail: jacques.balayla@mail.mcgill.ca. Department of Ob-
stetrics and Gynaecology. McGill University, Montreal, Quebec, Canada
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1 Overview of Fetal Circulatory Physiology
The fetal-maternal circulation interface is proximate at the placenta,
where gas/nutrient exchange between maternal and fetal circulation occurs.
Oxygen and nutrients diffuse across the placental membrane from maternal
arterial blood and is transported to the fetus via a single large umbilical
vein. Following tissue extraction of oxygen and nutrients, fetal blood re-
turns to the placenta via two umbilical arteries. This now deoxygenated
blood contains the waste products of fetal metabolism, including carbon
dioxide (pCO2), for elimination from maternal circulation via the lungs and
kidneys. As such, venous cord blood reflects the combined effect of maternal
acid-base status and placental function, whilst arterial cord blood reflects
fetal/neonatal acid-base status. The clinical value of cord blood gas analysis
in the immediate post-partum period lies in its ability to provide objective
evidence of asphyxia at the moment of birth, which is the main determi-
nant of short-term neonatal adaptation to extra-uterine life and long-term
neurological status (Steer et al., 1989). In this regard, cord blood has been
shown to be more reliable than routine clinical assessment at birth using the
APGAR scoring system (Steer et al., 1989).
2 Fetal Acid-Base Status and Metabolism
The pH, base excess and pCO2 of arterial blood flowing through the um-
bilical cord provides valuable objective evidence of the metabolic condition
of neonates at the moment of birth, including asphyxia. Asphyxia refers to
reduced tissue oxygen (hypoxia) of sufficient severity and duration to cause
metabolic acidosis. Metabolic acidosis develops when tissue cells are severely
depleted of oxygen and aerobic metabolism of glucose is compromised (Sykes
et al., 1982). Cells must therefore depend on less effective anaerobic path-
ways that result in reduced ATP (energy) production and accumulation of
metabolic acids (principally lactic acid). When normal buffering mecha-
nisms are overwhelmed by this acid influx, the fetal blood pH falls below
normal limits. Cord-blood metabolic acidosis – which is characterized by
reduced blood pH and decreased base excess (i.e. increased base deficit) –
thus implies that sometime during labor, oxygenation of fetal tissues was
severely compromised (Sykes et al., 1982).
3 Cardiotocography - Fetal Heart Rate (FHR)
Normal human labor is characterized by regular uterine contractions and
repeated episodes of transient interruption of fetal oxygenation (Parer et al.,
2006). Most fetuses tolerate this process well, but some do not. The fetal
heart rate (FHR) pattern helps to distinguish the former from the latter as
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it is an indirect marker of fetal cardiac and central nervous system responses
to changes in blood pressure, blood gases, and acid-base status (Parer et al.,
2006). Because of high interobserver and intraobserver variability in the
interpretation of fetal heart rate (FHR) tracings, the American College of
Obstetricians and Gynecologists (ACOG), the Society for Maternal-Fetal
Medicine (SMFM), and the United States National Institute of Child Health
and Human Development (NICHD) convened a workshop to standardize
definitions and interpretation of electronic fetal monitoring (EFM) (Ma-
cones et al., 2008). The rationale for intrapartum FHR monitoring is that
identification of FHR changes potentially associated with inadequate fetal
oxygenation may enable timely intervention to reduce the likelihood of hy-
poxic injury or death (Ray and Ray, 2017). Although virtually all obstetric
societies advise monitoring the FHR during labor, the benefit of this inter-
vention has not been clearly demonstrated and this position is largely based
upon expert opinion and medicolegal precedent (Alfirevic et al., 2017).
4 Fetal Heart Rate (FHR) Intepretation
Several tracing characteristics are used to interpret the FHR:
Table 1. NICHD - Variables inherent to FHR
Baseline rate
Variability
Accelerations
Decelerations
As mentioned previously, in 2008, the NICHD set forth recommendations
for defining FHR characteristics to improve predictive value of EFM and
facilitate evidence-based clinical management of fetal compromise (Macones
et al., 2008). The FHR definitions are intended for evaluation of intrapartum
patterns but may be used antepartum. A 3-tier FHR interpretation system
was developed, defining a category I FHR tracing as normal, category III
as abnormal, and category II as atypical or indeterminate. Category II or
III tracings may prompt intervention by the provider, be it intra-uterine
resuscitation and/or prompt delivery.
Table 2. NICHD - FHR Classification
Category I - Normal
Category II - Atypical
Category III - Abnormal
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5 Fetal Distress
Clinically, it is generally preferable to describe specific signs of suspected
fetal compromise in lieu of simply providing an all-encompassing diagnosis
of fetal distress (Parer and Livingston, 1990). These include:
· Decreased fetal movements felt by the mother
· Meconium in the amniotic fluid
· Non-reassuring patterns seen on cardiotocography such as:
· Fetal tachycardia and bradycardia
· Decreased variability in the fetal heart rate
· Late decelerations
Likewise, biochemical signs, assessed by fetal scalp blood sampling can
be indicative of fetal distress. In particular, a low pH and elevated blood
lactacte levels indicates fetal metabolic acidosis (Sykes et al., 1982). Some
of these signs are more reliable predictors of fetal compromise than others.
For example, cardiotocography can give high false positive rates, even when
interpreted by highly experienced medical personnel (Alfirevic et al., 2017).
Metabolic acidosis is a more reliable predictor, but is not always available.
6 Problems with the FHR interpretation
Over the last 30 years, little progress has been made in the screening
and diagnosis of fetal acidosis. Though some headway was made with the
widespread introduction of electronic fetal monitoring (EFM) in labour, the
presence of a marked pattern of late decelerations, a hallmark traditionally
associated with poor neonatal outcomes, has been shown to predict neonatal
acidosis in less than 50 percent of cases (Balayla and Shrem, 2019). Initially,
EFM was introduced into clinical practice without appropriate studies on its
validity (relationship of FHR patterns to fetal outcome), reliability (intra-
and inter-observer variability), and causal relationship to outcome (ability
of intervention to avoid metabolic acidemia). Because of the demonstra-
ble high inter-observer and intra-observer variability in the interpretation
of fetal heart rate (FHR) tracings (Balayla and Shrem, 2019), and despite
the NICHD management guidelines (Macones et al., 2008), EFM has not
substantially changed the incidence of neonatal hypoxia, hypoxic ischemic
encephalopathy, neonatal academia, cerebral palsy, or neurodevelopmental
impairment. Whereas some evidence suggests that intrapartum fetal mon-
itoring is associated with a reduction in intrapartum death and neonatal
seizures, a reduction in long-term neurologic disability – which is primarily
related to oxygen status at birth – has not been demonstrated (Alfirevic
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et al., 2017). Though EFM has moderate sensitivity, it has a low speci-
ficity for detecting fetal hypoxia/asphyxia. As a consequence, the high false-
positive rate of EFM for predicting adverse neonatal outcomes has increased
the rates caesarean delivery to an average of 33 percent in North America
since the 1970s, with elevated rates of associated maternal and neonatal
morbidity (Alfirevic et al., 2017).
Though the development of a systematic and objective method of analy-
sis and diagnosis in EFM was theorized to overcome the high inter-observer
variability in its interpretation, several large randomized controlled trials
(RCTs), including the international INFANT trial, have not demonstrated
improvements in neonatal outcomes when computerized and AI systems
were used for the quantitative and qualitative analysis of EFMs (Balayla
and Shrem, 2019). As we work toward realizing the full potential benefits of
EFM, finding the best assessment strategies to evaluate fetal pH in real-time
remains a key goal in Obstetrics.
7 The Obstetrical Paradox
It has been well established that fetal acid-base status is inextricably
linked to fetal heart rate patterns (Reddy et al., 2009). Since the EFM has
not been shown to reliably predict neonatal pH status or reduce adverse out-
comes, one fundamental conundrum, hereby termed the “Obstetrical Para-
dox”, arises: if the fetal heart rhythm is inextricably linked to fetal acid-base
status, why are neonatal outcomes not improved when tracing changes are
detected and acted upon? (Balayla and Shrem, 2019). Outside of human
error and delays in intervention, a potential solution to the obstetrical para-
dox may be related to the possibility that the modern interpretation of EFM
is incomplete - that other visible tracing characteristics we do not presently
account for are actually predictive of fetal pH and lead to better outcomes
when acted upon. A second possibility is that perhaps there is merely an
association and not a causal pathway between changes in pH and EFM fluc-
tuations. Such explanation would imply that there is no direct FHR-pH
relationship. Finally, it may be the case that the key to predicting fetal
pH lies embedded within EFM tracings but beyond their traditional clinical
interpretation as set by the NICHD (Macones et al., 2008). By applying the
Fourier Transformation and determining the frequency distribution of EFM
tracings, the FETAL technique seeks to delve into the EFMs’ fundamental
build-up components to test the latter hypothesis in a clinical setting.
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Figure 1. The Obstetrical Paradox and its potential solutions
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8 The Fourier Transform
The Fourier transform (FT) is a mathematical tool which decomposes
either a periodic or non-periodic continuous function of time, also known as
a signal, into individual sinusoidal waves of specific amplitude, frequency,
and phase shift (Stein and Shakarchi, 2011). The inverse Fourier transform
mathematically synthesizes the original time-dependent function from these
sinusoidal waves and their frequency domain representation.
As such, the Fourier transform can be used to yield the frequency spec-
trum of the original signal. Each sinusoidal component is itself a time-
dependent, complex-valued function of frequency, whose magnitude, or mod-
ulus, represents the amount of that frequency present in the original func-
tion. Likewise, its argument is the phase offset of the basic sinusoid for that
frequency. In practical terms, this means that the Fourier transformation of
a signal yields a list of individual sinusoidal functions with specific frequen-
cies and magnitudes, which when added, reveal the original function anew.
The Fourier transform is not limited to functions of time, but the do-
main of the original function is commonly referred to as the time domain.
Concretely, this means that any linear time-invariant system, such as the
fetal heart rate signal, can be expressed relatively simply as the sum of fre-
quencies of specific sine and cosine waves. When both the function and its
Fourier transform are replaced with discretized counterparts, it is called the
discrete Fourier transform (DFT). The DFT has become a mainstay of nu-
merical computing in part because of a very fast algorithm for computing it,
called the Fast Fourier Transform (FFT), which was known to Gauss (1805)
and was brought to light in its current form by Cooley and Tukey.
There are several common conventions for defining the Fourier transform
of an integrable function f : R→ C. For clarity, we will define the transform
equation as X(ω) since we’ll be addressing frequency in Hertz (e.g. if time
is measured in seconds, then the frequency is in Hertz):
X(ω) =
∫ ∞
−∞
x(t)e−2pijωtdt (1)
When the independent variable t represents time, the transform variable
ω represents frequency. Under suitable conditions, x(t) is determined by
X(ω) via the inverse transform:
x(t) =
∫ ∞
−∞
X(ω)e2pijωtdω (2)
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To render the above equation more manageable and to help integrate it,
we consider the Taylor series expansion:
f(x) =
∞∑
n=0
f (n)(x0)
n!
(x− x0)n (3)
Since ex is its own derivative, the Taylor series expansion for f(x) = ex
is rather simple:
ex =
∞∑
n=0
xn
n!
= 1 + x+
x2
2!
+
x3
3!
... (4)
When incorporating the complex plane into the definition, we obtain:
eiθ =
∞∑
n=0
(iθ)n
n!
= 1 + iθ − θ
2
2!
− iθ
3
3!
... (5)
so that for the set of all positive integers p:
cos(θ) =
∞∑
n=2p
(−1)n2
n!
θn (6)
and
sin(θ) =
∞∑
n=2p−1
(−1)n−12
n!
θn (7)
As such, all even order terms are real and all odd order terms are imag-
inary, thereby yielding Euler’s formula:
eiθ = cos(θ) + isin(θ) (8)
Re-writing sines and cosines as complex exponentials makes it necessary
for the Fourier coefficients to be complex valued. The usual interpretation
of this complex number is that it gives both the amplitude (or size) of the
wave present in the function and the phase (or the initial angle) of the wave.
These complex exponentials sometimes contain negative frequencies. If θ
is measured in seconds, then the waves e2ipiθ and e−2ipiθ both complete one
cycle per second, but they represent different frequencies in the transform.
Given a trajectory, the Fourier transform yields individal waves, each of
which has a strength, a delay and a speed (Stein and Shakarchi, 2011).
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The trajectory is processed through a set of filters, whereby each filter
yields a cycle and the remainder of the trajectory filters are independent.
Otherwise stated, each one catches a different part of the trajectory until
there are enough filters to catch all of the trajectory, ie, the last filter leaves
no trajectory remainder. The result cycles can be combined linearly, giving
the same results no matter the mixing order. In order to accomplish the
latter, two algorithms exist: the Discrete Fourier Transform (DFT), which
requires O(n2) operations (for n samples), and the Fast Fourier Transform
(FFT) which requires O(n.log(n)) operations (Stein and Shakarchi, 2011).
8.1 Frequency Domain
The frequency domain refers to the analysis of mathematical functions
or signals with respect to frequency, rather than time. Put simply, a time-
domain graph shows how a signal changes over time, whereas a frequency-
domain graph shows how much of the signal lies within each given frequency
band over a range of frequencies. A frequency-domain representation can
also include information on the phase shift that must be applied to each
sinusoid in order to be able to recombine the frequency components to re-
cover the original time signal. The ‘spectrum’ of frequency components
is the frequency-domain representation of the signal. The inverse Fourier
transform converts the frequency-domain function back to the time func-
tion. A spectrum analyzer is a tool commonly used to visualize electronic
signals in the frequency domain. Some specialized signal processing tech-
niques use transforms that result in a joint time–frequency domain, with
the instantaneous frequency being a key link between the time domain and
the frequency domain. Homogeneity means that a change in amplitude in
one domain produces an identical change in amplitude in the other domain.
This should make intuitive sense: when the amplitude of a time domain
waveform is changed, the amplitude of the sine and cosine waves making up
that waveform must also change by an equal amount.
8.2 Properties of the FT
The Fourier Transform is linear, that is, it possesses the properties of
homogeneity and additivity. Homogeneity means that a change in ampli-
tude in one domain produces an identical change in amplitude in the other
domain. Additivity of the Fourier transform means that addition in one
domain corresponds to addition in the other domain.
fˆ(ξ) =
∫ ∞
−∞
f(x)e−2piiξxdx↔ kfˆ(ξ) = k
∫ ∞
−∞
f(x)e−2piiξxdx (9)
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8.3 The Discrete Fourier Transformation
The integral range in equation (1) goes from −∞ to ∞. Since the fetal
heart rate signal is not periodic nor perpetual, this infinite integral will not
be a useful tool for this purpose. For the purposes of our analysis, we must
employ the Discrete Fourier Transform (DFT). The discrete Fourier trans-
form (DFT) converts a finite sequence of equally-spaced samples of a time
function into a same-length, equally-spaced complex-valued function of fre-
quency via an algorithm known as the Fast Fourier Transformation (FFT)
(Walker, 2017). The interval at which the DFT is sampled is the reciprocal
of the duration of the input sequence.
The DFT formula is defined as:
Xk =
N−1∑
n=0
xn · e− i2piN kn (10)
where N refers to the total number of samples, n refers to the ‘nth’ sample,
xn refers to the function value at the nth sample, and k is the frequency
attributed to the ensuing sine wave at the ‘nth’ sample.
The analogue to the continuous form in the case of the discrete form is
as follows:
ω =
k
N
(11)
and
n = t (12)
This relationship can be re-written as:
Xk =
N−1∑
n=0
xn · e− i2piN kn = x0e−b0i + x1e−b1i + ...+ xne−bN−1i (13)
where bN = 2pi
kn
N , Xk is the ‘kth’ frequency bin and xn is the ‘nth’ sample.
By considering Euler’s Formula in (8) and replacing θ with b0, we can
expand equation (13) as follows:
Xk = x0[cos(−b0) + isin(−b0)] + ...+ xn[cos(−bN−1) + isin(−bN−1)] (14)
We can further express the Xk relationship as:
Xk = Ak +Bki (15)
where Ak = x0cos(−b0) and Bk = x0sin(−b0)
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With this notation, we can represent Xk in the complex plane in vector form:
0 1 2 3 4 5
0
1
2
3
4
5
Real
I
m
a
g
in
a
ry
(i
)
X k
Ak
B
k
i
Note each component of Xk in red, in each axis.
To calculate the magnitude of the vector, which will give us the magni-
tude of the frequency component, we simply apply Pythagoras’ theorem, as
follows:
|Xk| =
√
A2k +B
2
k (16)
Likewise, to calculate phase shift θ for the sinusoidal wave with that
particular frequency we need to use the arctan function:
θ = arctan (
Bk
Ak
) (17)
An N-point DFT is expressed as the multiplication X=Wx, where x is
the original input signal, W is the N-by-N square DFT matrix, and X is the
DFT of the signal. The transformation matrix W can be defined as W =(
ωik√
N
)
i,k=0,...,N−1
, or otherwise stated:
W =
1√
N

1 1 1 1 · · · 1
1 ω ω2 ω3 · · · ωN−1
1 ω2 ω4 ω6 · · · ω2(N−1)
1 ω3 ω6 ω9 · · · ω3(N−1)
...
...
...
...
. . .
...
1 ωN−1 ω2(N−1) ω3(N−1) · · · ω(N−1)(N−1)

where ω = e−2pii/N is a primitive Nth root of unity in which i2 = −1.
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9 Fourier Transform in FHR analysis
The utility of the Fourier transformation in the analysis of FHR stems
from the spectrum analysis of the frequency-domain, which is aided by a fun-
damental theorem in probabilistic theory, namely, the law of large numbers
(Hsu and Robbins, 1947).
9.1 The Law of Large Numbers
Two different versions of the law of large numbers exist; they are called
the strong law of large numbers, and the weak law of large numbers (Hsu and
Robbins, 1947). Stated for the case where X1, X2, ... is an infinite sequence
of independent and identically distributed Lebesgue integrable random vari-
ables with expected value E(X1) = E(X2) = ...= µ, both versions of the law
state that – with virtual certainty – the sample average:
Xn =
1
n
(X1 + · · ·+Xn) (18)
converges to the expected value
Xn → µ for n→∞ (19)
Otherwise stated, as n→∞
P (limXn = µ) = 1 (20)
Though a frequency-domain spectrum is not an individual variable, the
law of large numbers still applies regarding its range. If we assume that
a normal fetal physiologic state exists from fetus to fetus, their individual
FHR frequency spectrum range, on average, will be composed of similar
frequencies. By sampling an ever-increasing number of FHRs with normal
pH at birth, we can determine the expected frequency spectrum range in a
normal fetus and its 95 percent confidence interval. While not a theoreti-
cal pre-test calculation, this established range can be used as the expected
theoretical value against which future assessments can be compared. This
allows us to contrast between a fetus with normal frequency parameters and
one without. Whether an abnormal frequency spectrum is associated with
an abnormal pH is what this technology seeks to determine.
9.2 The Kolmogorov–Smirnov test (K–S test)
As mentioned previously, the law of large numbers will allow us to es-
tablish a reference range for the normal frequency domain of the FHR of
a term fetus. Once an expected, reference curve is created, we can use
it to compare any individual fourier-transformed FHR strip against it to
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determine whether its shape is significantly different with the use of the
Kolmogorov–Smirnov test. The Kolmogorov–Smirnov test, or K-S test for
short, is a nonparametric test of the equality of continuous, one-dimensional
probability distributions that can be used to compare a sample with a ref-
erence probability distribution (one-sample K–S test), or to compare two
individual samples (two-sample K–S test). With a one-sample K-S test, a
distribution is tested for normality. That is, it is tested against a normal
Gaussian distribution of mean µ and variance σ2 (Lopes et al., 2007). In the
case of the FETAL technique, we will use the two-sample K-S test to com-
pare a given Fourier-transformed FHR strip to the reference curve. Simply
stated, the Kolmogorov–Smirnov statistic quantifies a distance between the
empirical distribution function of the sample and the cumulative distribu-
tion function of the reference distribution.
The empirical distribution function Fn for n independent and identically
distributed ordered observations Xi is defined as:
Fn(x) =
1
n
n∑
i=1
I[−∞,x](Xi) (21)
where I[−∞,x](Xi) is the indicator function, equal to 1 if Xi ≤ x and
equal to 0 otherwise.
The Kolmogorov–Smirnov statistic Dn for a given cumulative distribu-
tion function F (x) is given by the equation:
Dn = sup
x
|Fn(x)− F (x)| (22)
where supx is the supremum of the set of distances between both distribu-
tions. When using a two-sample K-S test, the Kolmogorov–Smirnov statistic
can be defined as:
Dn,m = sup
x
|F1,n(x)− F2,m(x)| (23)
For large samples, the null hypothesis is rejected at level α, the proba-
bility of rejecting the null hypothesis when the null hypothesis is true, if:
Dn,m > c(α)
√
n+m
nm
(24)
Where n and m m are the sizes of first and second sample respectively.
The value of c(α) is given by the equation below:
c(α) =
√
−1
2
lnα (25)
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9.3 Dimensionality of the Fourier Transform
When the time-domain signal is transformed into a frequency-domain
via the fourier transform, the axes change. While in the time-domain the
independent axis is time, the independent axis in the frequency domain is
that of frequency in Hertz (Hz), and thus, it is time-independent. In both
cases the dependent, y axis is the amplitude or intensity of the signal. A
theoretical example of a FHR strip is presented here:
20 40 60 80 100 120 140
100
120
140
160
180
time(sec)
bpm
Likewise, a computerized power spectrum analysis of the frequency domain
by Romano et al. (Romano et al., 2016) is seen below. Note its bimodal/bi-
band distribution in the low and high-frequency range:
9.4 Physiological basis for the FETAL technique
Heart rate variability investigations started in Obstetrics, with the ob-
servation that changes in FHR variability precede changes in actual heart
rate in cases of intrauterine asphyxia. Indeed, the heart rate depends on the
sinus node’s intrinsic rate and sympathetic-parasympathetic nervous tone
balance, which themselves are directly dependent on present oxygenation
status (Doret et al., 2015). Power spectral analysis and Fourier transforma-
tion of FHR variability has shown that sympathetic and parasympathetic
nervous activities make frequency-specific contributions to the heart rate
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power spectrum, and that renin-angiotensin system activity strongly mod-
ulates the amplitude of the spectral peak located at 0.04 Hz. Specifically in
the non-anomalous term fetus, heart rate variability estimated by the high-
frequency (HF) bands between 0.35–0.45 Hz reflects FHR control by the
parasympathetic tone and the low-frequency (LF) bands between 0.03–0.15
Hz reflects the sympathetic tone. Studies of heart rate fluctuation based
on frequency analysis have been carried out in animal models. However,
their clinical application in humans has not been studied as of yet. Pre-
vious studies have found that the shift of autonomic balance is related to
the redistribution of the power between the LF and HF bands, and that
normalized power units or LF/HF are effective methods of determining the
shift of autonomic balance – the mechanism presumed to be at the helm of
fetal acid-base status. A higher proportion of LF bands evokes a predom-
inantly sympathetic environment, which is indicative of a stress response.
What threshold of that stress response is indicative of fetal hypoxemia is
unknown. By studying specific low- and high-frequency patterns of Fourier-
transformed domains, the FETAL Study seeks to determine whether fetal
acid-base status evaluations can be made non-invasively and in real-time.
Examples by Doret et al. of Fast Fourier Transformations, power spectrum
densities (PSD) and log-converted frequency wavelet distributions superim-
posed on the PSD of the EFM are illustrated here (Doret et al., 2015):
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9.5 Procedural Steps for the FETAL Technique
In order to develop this technology for clinical use, we first need to obtain
a reference range of Fourier-transformed frequencies in a normal newborn
population. Based on statistical inference, we would need a minimum of 500
tracings of newborns with normal umbilical artery pH levels between 7.15
- 7.35, in the context of normal base excess and lactate levels. This would
allow us to determine a normal reference range in the frequency domain
against which we can compare future frequency distributions. Using the dis-
crete Fourier transformation and the Kolmogorov–Smirnov test in real-time
at the bedside, we can assess whether a frequency distribution significantly
deviates from the reference range developed. Such deviation would be a
warning sign prompting an intervention from the provider to reduce rates
of abnormal pH. Likewise, distributions consistent with the reference range
are re-assuring and need not prompt immediate action. Rates of Caesarean
and assisted-vaginal delivery are expected to decrease as a consequence.
10 Conclusion
Adequate fetal and neonatal development depend upon the presence of a
normal acid-base environment during pregnancy and the smooth transition
from intra-uterine to extra-uterine life. Current screening methods using the
EFM are inadequate to predict and prevent injury, likely as a consequence
of the poor inter-rater reliability observed amongst healthcare professionals.
While we do not expect the FETAL technique, should it be successful, to
completely overcome the issues pertaining to inter-rater reliability as well
as the intricacies of clinical decision making, it is conceivable that outcomes
would be improved relative to their state today. Indeed, we hypothesize
that the improvement in the sensitivity and specificity of the EFM with the
use of the FETAL technique will lead to a significant reduction in the rate
of neonatal hypoxic injury and in the rate of caesarean and assisted vaginal
deliveries for suspected fetal distress. The implications of a successful appli-
cation of the FETAL technique would have paradigm-shifting consequences
in the provision of modern obstetrical care.
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